Related Experiment Video
Updated: Oct 7, 2025

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.0K
Cost-Benefit Analysis of Novel Antiviral Ritonavir in the Active Duty U.S. Military Population
Daphne Morrison Ponce1, Levi K Kitchen1, John J Devlin2
1Department of Emergency Medicine, Naval Medicine Readiness and Training Command, Portsmouth, VA 23708, USA.
Military Medicine
|January 5, 2022
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Antimicrobial Effectiveness
293
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
293
Retrovirus Life Cycles
47.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.3K
Therapeutic Drug Monitoring: Affecting Factors
8
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
8

